Orthogen LLC is a research and development company specializing in the creation of innovative bone graft products and medical devices. Formerly a division of BioLok International, Inc, Orthogen now focuses on developing new generations of bone graft materials, orthopedic implants, prostheses, and other medical technologies.
With a strong emphasis on research and development, Orthogen is currently scaling up its cutting-edge technologies, including a completely resorbable synthetic bone graft product called DentoGen. Additionally, the company is clinically testing a patented nanocomposite bone graft material, DentoGen-CR, which stimulates bone regeneration as it degrades in the body.
Generated from the website